Biogenes Technologies: Changing Biotech With Synthetic Antibodies
Adrian Joseph, Co-Founder & Chief Commercial Officer, Biogenes Technologies
11-Apr-23 10:30

Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
Biogenes Technologies is trying to change the biotech landscape by creating and commercialising synthetic antibodies for mass use in all kinds of test kits. However building and scaling a deeptech startup like this can be challenging here in Malaysia without the right help.
We speak to Adrian Joseph, Co-Founder & Chief Commercial Officer, of Biogenes Technologies about the startup’s journey and mission, and how Cradle Fund has supported them along the way.
Produced by: Roshan Kanesan
Presented by: Roshan Kanesan
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: markets, technology, economy, medical advances, entrepreneurs, SME, managing disease
Tags: biotech, medical, digital healthcare, healthcare,